Octavio Espinoza, CFO: Ligand Pharmaceuticals LGND Sell · Filed 03/06

Trade details

Type: Insider sale
Amount: $510,834.87
Shares · price: 2,457 sh · $207.91 a share
Held after: 25,075 sh
Stock: Ligand Pharmaceuticals LGND
Person: Octavio EspinozaCFO
Trade date: 26/03/04
Filed: 26/03/06
Days to filing: 2 days

Sold 8.9% of holdings

Share of holding sold: 8.9%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/02~04/03

Octavio Espinoza's recent trades

Octavio EspinozaCFO
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$9.1M
31,641 sh
$9.1M
Filed 08/12
Traded 08/12
Octavio EspinozaCFO
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$687.8K
3,057 sh
$687.8K
Filed 03/13
Traded 03/11
Octavio EspinozaCFO
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$649K
3,057 sh
$649K
Filed 03/11
Traded 03/11
Octavio EspinozaCFO
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$712.6K
3,413 sh
$712.6K
Filed 03/06
Traded 03/04
Octavio EspinozaCFO
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$328.5K
1,588 sh
$328.5K
Filed 03/06
Traded 03/04

Octavio Espinoza, CFO — sold $510.8K of Ligand Pharmaceuticals LGND · 8.9% of holdings · 10b5-1 plan | Whalegun